Edwards Lifesciences Corporation received notice from Robert W.A. Sellers, Senior Vice President, Principal Accounting Officer of the Company, of his decision to retire, effective as of July 1, 2024 . On the Retirement Date, Mr. Sellers will be succeeded by Andrew M. Dahl, currently Senior Vice President and Corporate Controller of the Company. Mr. Dahl, age 47, joined Edwards in February 2024 as Corporate Controller.

Prior to joining Edwards, Mr. Dahl served in positions of increasing responsibility at Medtronic PLC, a medical device company, since May 2016, serving most recently as Vice President and Global Assistant Controller. Before joining Medtronic PLC, Mr. Dahl served as Director of Internal Audit at Polaris Industries from July 2010 to May 2016, and as a Senior Manager at Deloitte & Touche LLP from May 2002 to July 2010. Mr. Dahl holds a Bachelor of Arts in Accounting from the University of San Diego.